Update on Hepatitis B and D in People With or At-Risk for HIV Coinfection

Debika Bhattacharya MD, MSc
Clinical Professor, Division of Infectious Diseases
University of California Los Angeles

CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Bhattacharya is a Clinical Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles with a joint appointment at the Greater Los Angeles VA Healthcare System. Her research has focused on clinical outcomes in persons living with HIV and viral hepatitis, and, more recently, clinical therapeutics for HBV, which have been funded through NIH support. She is the Chair of the Hepatitis Transformative Science Group (TSG) within the AIDS Clinical Trials Group (ACTG), where she leads the scientific agenda for novel HBV therapeutics for the world’s largest HIV clinical trials organization. She is the IDSA co-chair of the AASLD/IDSA Hepatitis C Treatment Guidance Panel. Her roles at the GLAVAHCS include being co-director of the Viral Hepatitis Program of the Greater Los Angeles Veterans Affairs Healthcare System (GLAVAHS) and co-Director of the NODES program. She is also a member of the Writing Panel for the NIH-CDC-HIVMA/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Know about risks for hepatitis B and D in People with or At Risk for HIV Co-Infection.
2. Understand HBV prevention strategies in those with HIV.
3. Be aware of current HBV management considerations in those living with HIV.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for October 11, 2023, as a live activity. This activity will also be available as an enduring activity from October 18, 2023, through October 10, 2026.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Peter J. Meacher (Moderator) has no relevant financial relationships to disclose.
- Dr. Debika Bhattacharya (Presenter) has had the following relevant financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Institutional Research Grant from Gilead. Dr. Bhattacharya submitted her slides in advance for adequate peer review and supported her presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register